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1. To examine the effects of high insulin levels
(100 nM) on cell proliferation in MDA-MB-231
and MCF-10a cells.
2. To examine activation of PI3-kinase and
MAP-kinase cell signalling pathways after
insulin treatment.
3. To examine the role of PI3-kinase and MAP-
kinase cell signalling pathways in insulin-
mediated cell proliferation.
Breast cancer is prevailing as the most diagnosed
cancer in women. Obesity and its co-morbidities,
including type-II diabetes, are increasing to epidemic
proportions.
A pathological link between obesity, breast cancer
risk and mortality has been established recently1.
Insulin resistance is a pre-malignant indicator of
type-II diabetes and closely linked with obesity. Its
molecular implications result in chronically elevated
circulating insulin plasma levels.
Here we examine the effect of high insulin levels on
cell proliferation, activation of PI3-kinase and MAP-
kinase cell signalling pathways in estrogen-receptor
negative (ER-) breast cancer cells (MDA-MB-231) and
on normal breast epithelial cells (MCF-10a).
1. Further preliminary results indicate an activation
of MAP-kinase cell signalling pathway after 15
min of insulin treatment in MCF-10a cells (data
not shown).
2. Insulin may initiate carcinogenesis of breast
epithelial cells by increasing cell proliferation
(MCF-10a), rather than increasing cancer
progression of existing tumours (MDA-MB-231).
3. These effects may be mediated by insulin
activating the MAP-kinase pathway.
4. The MAP-kinase pathway may be a future target
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Effects of high insulin levels on cell proliferation
BrdU-incorporation was used to measure DNA-synthesis after
24 and 48 h treatment with 100 nM insulin
High insulin concentrations increased cell
proliferation in normal breast epithelial cells, but not
in ER- breast cancer cells.
Results
Effect of high insulin levels on activation of PI3-
kinase and MAP-kinase cell signalling pathways
ELISA kits were used to measure Akt and ERK1/2
phosphorylation after 5 and 10 min treatment with 100 nM
insulin and with/without pre-treatment (100 nM wortmannin or
50 µM PD98059).
High insulin concentrations activated the PI3-kinase,
but not the MAP-kinase cell signalling pathway in ER-
breast cancer cells and in normal breast epithelial
cells.
Results
Inhibition of cell signalling pathways and effects
on cell proliferation after insulin stimulation
DNA-synthesis was measured during 24 h treatment with 100
nM insulin following cell signalling pathway inhibition by 1 h







Inhibition of the MAP-kinase pathway reduced cell
proliferation in ER- breast cancer cells. In normal
breast epithelial cells, inhibition of MAP-kinase
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